首页> 外文期刊>Regenerative Biomaterials >In situ cardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patches
【24h】

In situ cardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patches

机译:使用神经肽物质P和IGF-1C肽洗脱心脏斑块的原位心脏再生

获取原文
       

摘要

Cardiovascular diseases cause huge socio-economic burden worldwide. Although a mammalian myocardium has its own limited healing capability, scaffold materials capable of releasing stem cell recruiting/engrafting factors may facilitate the regeneration of the infarcted myocardium. The aim of this research was to develop cardiac patches capable of simultaneously eluting substance P (SP) and insulin-like growth factor-1C (IGF-1C) peptide. Polycaprolactone/collagen type 1-based patches with or without SP and IGF-1C peptide were fabricated by co-electrospinning, which exhibited nanofibrous morphology. SP and IGF-1C/SP patches recruited significantly higher numbers of bone marrow-mesenchymal stem cells than that of the negative control and patch-only groups in vitro. The developed patches were transplanted in an infarcted myocardium for up to 14?days. Mice underwent left anterior descending artery ligation and received one of the following treatments: (i) sham, (ii) saline, (iii) patch-only, (iv) IGF-1C patch, (v) SP patch and (vi) IGF-1C/SP patch. SP and IGF-1C/SP patch-treated groups exhibited better heart function and attenuated adverse cardiac remodeling than that of the saline, patch-only and individual peptide containing cardiac patches. SP patch and IGF-1C/SP patch-treated groups also showed higher numbers of CD31-positive vessels and isolectin B4-positive capillaries than that of other groups. IGF-1C/SP-treated group also showed thicker left ventricular wall in comparison to the saline and patch-only groups. Moreover, IGF-1C/SP patches recruited significantly higher numbers of CD29-positive cells and showed less numbers of Tunel-positive cells compared with the other groups. These data suggest that SP and IGF-1C peptides may act synergistically for in situ tissue repair.
机译:心血管疾病在世界范围内造成巨大的社会经济负担。尽管哺乳动物心肌具有其自身有限的愈合能力,但是能够释放干细胞募集/移植因子的支架材料可以促进梗塞心肌的再生。这项研究的目的是开发能够同时洗脱P物质(SP)和胰岛素样生长因子1C(IGF-1C)肽的心脏贴剂。通过共电纺丝制备具有或不具有SP和IGF-1C肽的聚己内酯/ 1型胶原蛋白贴剂,其表现出纳米纤维形态。在体外,SP和IGF-1C / SP贴片募集的骨髓间充质干细胞数量明显高于阴性对照组和仅贴片组。发育的斑块被移植到梗死的心肌中长达14天。小鼠进行左前降支结扎并接受以下治疗之一:(i)假手术,(ii)盐水,(iii)仅贴片,(iv)IGF-1C贴片,(v)SP贴片和(vi)IGF -1C / SP补丁。 SP和IGF-1C / SP贴剂治疗组比盐水,仅贴剂和个别含肽的心脏贴剂具有更好的心脏功能并减轻不良心脏重塑。 SP贴片和IGF-1C / SP贴片治疗的组也显示出比其他组更高的CD31阳性血管和isolectin B4阳性毛细血管数目。与生理盐水和仅贴剂组相比,IGF-1C / SP治疗组的左心室壁也较厚。此外,与其他组相比,IGF-1C / SP贴片募集了更多数量的CD29阳性细胞,并显示出更少的Tunel阳性细胞。这些数据表明SP和IGF-1C肽可能协同作用于原位组织修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号